Article may be outdated

This article is 7 days old. Some details may have changed since publication.

Eyewire+·3 min read·hard

Epion Therapeutics Reports Association Between Keratoconus Severity and Endothelial Cell Density in Phase 3 Study

H
https://fyra.io
Epion Therapeutics Reports Association Between Keratoconus Severity and Endothelial Cell Density in Phase 3 Study
✦AI Summary

A phase 3 study published in Cornea found that while corneal endothelial cell density decreases with age and keratoconus severity, it generally remains within a healthy physiological range. The study analyzed baseline data from 477 eyes.

Why it matters

Understanding baseline corneal health is essential for evaluating the safety and efficacy of new treatments for keratoconus.

✦Dive DeeperCreate a free account to unlock

Mean baseline ECD was 2,802 285 cells/mm across 477 eyes, with only one eye below 2,000 cells/mm

Epion Therapeutics announced the publication of a peer-reviewed study in Cornea demonstrating that corneal endothelial cell density (ECD) declines significantly with increasing keratoconus severity and age but remains within the physiological range in nearly all affected eyes. 1

The study, conducted in collaboration with the Corneal Image Analysis Reading Center (CIARC) at the UH Eye Institute in Cleveland, analyzed baseline data from 254 patients (477 eyes) enrolled across 11 clinical sites in Epion's phase 3 program evaluating EpiSmart epithelium-on corneal cross-linking for keratoconus.

Using specular microscopy and corneal tomography, investigators examined associations between central ECD and several indicators of keratoconus severity, including corneal curvature, thickness, and elevation.

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
healthscience
✦

Get smarter about the news

Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.

Create free account

Already have an account? Sign in